According to the results of a survey conducted by the research company Active Group and the analytical center Experts Club in early February, 52.3% of respondents said that the prices of medicines they buy regularly have increased significantly, 43.9% said they have increased slightly, 3.6% said they have not changed, and 0.2% said they have decreased.
“The widespread perception of rising prices is a factor that directly affects adherence to treatment,” said Experts Club founder Maksim Urakin.
“Rising prices are prompting some patients to delay purchases and self-medicate, which increases the risk of complications,” said Active Group CEO and co-founder Alexander Pozniy.
The survey was conducted on the SunFlowerSociology online panel using a representative sample on February 11-12, 2026. The survey involved 1,000 respondents from a representative sample in all regions of Ukraine, except for the temporarily occupied territories.
